APA

Perez E. A., Hillman D. W., Dentchev T., Le-Lindqwister N. A., Geeraerts L. H., Fitch T. R., Liu H., Graham D. L., Kahanic S. P., Gross H. M., Patel T. A., Palmieri F. M. & Dueck A. C. (20100506). North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Perez E A, Hillman D W, Dentchev T, Le-Lindqwister N A, Geeraerts L H, Fitch T R, Liu H, Graham D L, Kahanic S P, Gross H M, Patel T A, Palmieri F M and Dueck A C. 20100506. North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Perez E. A., Hillman D. W., Dentchev T., Le-Lindqwister N. A., Geeraerts L. H., Fitch T. R., Liu H., Graham D. L., Kahanic S. P., Gross H. M., Patel T. A., Palmieri F. M. and Dueck A. C. (20100506). North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Perez E A, Hillman D W, Dentchev T, Le-Lindqwister N A, Geeraerts L H, Fitch T R, Liu H, Graham D L, Kahanic S P, Gross H M, Patel T A, Palmieri F M and Dueck A C. North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20100506.